CTLA4 and neoplasm: The gene expression profile in CMS3 TME of KRASmut shows upregulation of CD40, CTLA4, ARG1, STAT3, IDO, and CD274, making it a key regulator of immune suppression in TME regions surrounding the KRASmut tumor.